May #144 : Cholesterol Downer - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

HIV: Behind the Music

Taking Care of Business




Not by Meds Alone

No Viral Load=No Transmission?

The Stand

Staphing Up

Mixology

Heads of the Class

Heartburn Hotel

Protein Shakers

Mercury Rising

Britain: Hep C Rings Twice

Pill-Taking Tip

Cardio Risk Raiser

Cholesterol Downer




What's a Girl to Do?

Runaway Hit

The Mother of All HIV Tests

Lights! Camera! Bareback Action!

Prom Night Prep

Apply as Directed

Strong-arming HIV

Healing Fields

Jargon: DWI

Keeping Up With the Joneses

Melrose Place 2.0

Silence=Meth

Rock Out

Ladies First




Editor's Letter-May 2008

Mailbox-May 2008



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

May 2008


Cholesterol Downer

by Laura Whitehorn

A study called ENHANCE has revealed that people taking the cholesterol-lowering drug Vytorin, a combo of the statins Zetia (ezetimibe) and Zocor (simvistatin), didn’t end up with a lower risk of heart attack than those on Zocor alone. (In Vytorin, Zetia cuts cholesterol in the intestines, Zocor in the liver.) Vytorin did lower LDL (“bad” cholesterol) more than solo Zocor. But that didn’t shrink the amount of plaque in arteries, which is linked to heart attacks.

Daniel Lee, MD, who treats heart disease in people with HIV at the University of California San Diego, advises people to continue taking their cholesterol meds. Lee calls ENHANCE’s results inconclusive, adding that Zetia’s benefits for those with high LDL have been proven. (Many positive people battle high cholesterol; due to HIV-med interactions, most pair Zetia with statins other than Zocor.) “Lowering LDL is still the main thing,” Lee says. A heart-healthy diet has been shown to help lower LDL, so he also prescribes a visit to a dietician.                                  


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         

[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    andais
    Red House
    West Virginia


    zeze42
    Bay Area - Peninsula
    California


    ernienyc
    Bronx
    New York


    clintonjrsyr
    syracuse
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.